Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 5 of 5 items.
Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity
AlertHealth professional risk communication | 2019-05-21
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
AlertHealth professional risk communication | 2019-01-30